VERTEX PHARMACEUTICALS INC
VRTX · NASDAQ
Updated at 2026-10-13 13:44:08
- Today's High
- $508.57
- Today’s Low
- $497.52
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $512.44
- Previous Close
- $507.00
- Volume
- 952.74K
- Market Cap
- $128.5B
- P/E Ratio
- 29.45X
- EPS
- $17.18
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 50 NORTHERN AVENUE, BOSTON, MA, UNITED STATES, 02210
- Country
- US
- Listing Date
- 1991-07-24
- Fiscal Year End
- December
- Shares Outstanding
- 253.81M
- CIK
- 0000875320
- Website
- www.vrtx.com
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$3.33B
2026-03-31
$2.98B
2025-12-31
$3.22B
2025-09-30
$3.07B
Operating Expenses
2026-06-30
$1.59B
2026-03-31
$1.45B
2025-12-31
$1.46B
2025-09-30
$1.47B
Net Income
2026-06-30
$1.09B
2026-03-31
$1.03B
2025-12-31
$1.19B
2025-09-30
$1.08B
Net Profit Margin
2026-06-30
32.98%
2026-03-31
34.53%
2025-12-31
36.9%
2025-09-30
35.2%
Earnings Per Share
2026-06-30
$4.20
2026-03-31
$4.47
2025-12-31
$5.03
2025-09-30
$4.80
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$1.44B
2026-03-31
$1.3B
2025-12-31
$1.39B
2025-09-30
$1.35B
Effective Tax Rate
2026-06-30
20.97%
2026-03-31
17.67%
2025-12-31
10.51%
2025-09-30
16.62%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $3.33B | $2.98B | $3.22B | $3.07B |
| Operating Expenses | $1.59B | $1.45B | $1.46B | $1.47B |
| Net Income | $1.09B | $1.03B | $1.19B | $1.08B |
| Net Profit Margin | 32.98% | 34.53% | 36.9% | 35.2% |
| Earnings Per Share | $4.20 | $4.47 | $5.03 | $4.80 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $1.44B | $1.3B | $1.39B | $1.35B |
| Effective Tax Rate | 20.97% | 17.67% | 10.51% | 16.62% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.